S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-0.15%) $77.99
Gas
(0.37%) $2.15
Gold
(0.06%) $2 310.10
Silver
(0.36%) $26.79
Platinum
(0.09%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Aktualne aktualizacje dla Advicenne SA [ADVIC.PA]

Giełda: EURONEXT Branża: Biotechnology
Ostatnio aktualizowano1 saus. 1970 @ 03:00

0.00% 6.50

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy...

Stats
Dzisiejszy wolumen 63 830.00
Średni wolumen 45 756.00
Kapitalizacja rynkowa 0.00
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -3.67
ATR14 €0 (0.00%)

Advicenne SA Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Advicenne SA Finanse

Annual 2022
Przychody: €2.94M
Zysk brutto: €1.83M (62.05 %)
EPS: €-1.160
FY 2022
Przychody: €2.94M
Zysk brutto: €1.83M (62.05 %)
EPS: €-1.160
FY 2019
Przychody: €2.00M
Zysk brutto: €-10.85M (-542.73 %)
EPS: €-1.680
FY 2018
Przychody: €1.19M
Zysk brutto: €-7.27M (-610.76 %)
EPS: €-0.620

Financial Reports:

No articles found.

Advicenne SA

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej